RUBCN and metabolic dysfunction-associated steatotic liver disease: Collectively these data indicated that down-regulation of Rubicon was a prerequisite for MCFAs to rescue autophagy in fat-loaded hepatic cells and could be a potential target for drug therapy for NAFLD.